Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR4453 host gene (MIR4453HG) is a long non-coding RNA (lncRNA) gene located on chromosome 4, also known by aliases DKFZP434I0714 and LINC02486[1][2][4]. As a member of the lncRNA and miRNA host gene classes, its primary known feature is to host the MIR4453 microRNA within its sequence, potentially functioning in the regulation of gene expression at the post-transcriptional level. There is an association reported between MIR4453HG and chronic kidney disease, but evidence for other direct biological or disease functions is limited. It is not currently considered a therapeutic target, nor are there any approved drugs or known biomarkers related to its clinical manipulation[2].
Not applicable (no known therapeutics target this lncRNA directly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR4453 host gene (MIR4453HG).